Cognitive Behavioral Therapy for Insomnia May Improve Sleep and Pain in Crohn’s Disease: A Waitlist Control Pilot Trial
This study provides preliminary evidence of efficacy of CBT-I in people with CD. CBT-I improved self-reported sleep and may improve pain and CD symptoms. The results highlight the importance of addressing sleep concerns in inflammatory bowel disease, particularly in people with persistent pain or fatigue. Future trials powered to detect changes in pain and inflammation are warranted.
Authors
- Kelly A. Aschbrenner (ORCID: https://orcid.org/0000-0001-6243-2421)
- Jessica K. Salwen‐Deremer (ORCID: https://orcid.org/0000-0001-6498-3729)
- Michael T. Smith (ORCID: https://orcid.org/0000-0001-9373-1221)
- Corey A. Siegel (ORCID: https://orcid.org/0000-0002-2240-6605)
- Sarah J. Westvold (ORCID: https://orcid.org/0009-0004-2060-2137)
Institutions
- Dartmouth Institute for Health Policy and Clinical Practice (US)
- Dartmouth–Hitchcock Medical Center (US)
- Johns Hopkins University (US)
- Johns Hopkins Medicine (US)
- Yale University (US)
- Behavioral Pharma (United States) (US)
Publication Details
- Journal
- Inflammatory Bowel Diseases
- Published
- 2025-08-20
- DOI
- https://doi.org/10.1093/ibd/izaf210
- Primary Topic
- Sleep and related disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00